Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics
Abstract
The auristatin class of microtubule destabilizers are highly potent cytotoxic agents against several cancer cell types when delivered as antibody drug conjugates. Here we describe the high resolution structures of tubulin in complex with both monomethyl auristatin E and F and unambiguously define the trans-configuration of both ligands at the Val-Dil amide bond in their tubulin bound state. Moreover, we illustrate how peptidic vinca-site agents carrying terminal carboxylate residues may exploit an observed extended hydrogen bond network with the M-loop Arg278 to greatly improve the affinity of the corresponding analogs and to maintain the M-loop in an incompatible conformation for productive lateral tubulin-tubulin contacts in microtubules. Our results highlight a potential, previously undescribed molecular mechanism by which peptidic vinca-site agents maintain unparalleled potency as microtubule-destabilizing agents.
- Authors:
- Publication Date:
- Research Org.:
- Seattle Genetics, Inc., Bothell, WA (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); Swiss National Science Foundation (SNSF); Seattle Genetics Inc
- OSTI Identifier:
- 1337464
- Alternate Identifier(s):
- OSTI ID: 1903867
- Grant/Contract Number:
- AC02-05CH11231; 310030B_138659
- Resource Type:
- Published Article
- Journal Name:
- PLoS ONE
- Additional Journal Information:
- Journal Name: PLoS ONE Journal Volume: 11 Journal Issue: 8; Journal ID: ISSN 1932-6203
- Publisher:
- Public Library of Science (PLoS)
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; tubulins; crystal structure; hydrogen bonding; microtubes; nucleotides; dimers; valine; molecular structure
Citation Formats
Waight, Andrew B., Bargsten, Katja, Doronina, Svetlana, Steinmetz, Michel O., Sussman, Django, Prota, Andrea E., and Komarova, ed., Yulia. Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics. United States: N. p., 2016.
Web. doi:10.1371/journal.pone.0160890.
Waight, Andrew B., Bargsten, Katja, Doronina, Svetlana, Steinmetz, Michel O., Sussman, Django, Prota, Andrea E., & Komarova, ed., Yulia. Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics. United States. https://doi.org/10.1371/journal.pone.0160890
Waight, Andrew B., Bargsten, Katja, Doronina, Svetlana, Steinmetz, Michel O., Sussman, Django, Prota, Andrea E., and Komarova, ed., Yulia. Fri .
"Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics". United States. https://doi.org/10.1371/journal.pone.0160890.
@article{osti_1337464,
title = {Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics},
author = {Waight, Andrew B. and Bargsten, Katja and Doronina, Svetlana and Steinmetz, Michel O. and Sussman, Django and Prota, Andrea E. and Komarova, ed., Yulia},
abstractNote = {The auristatin class of microtubule destabilizers are highly potent cytotoxic agents against several cancer cell types when delivered as antibody drug conjugates. Here we describe the high resolution structures of tubulin in complex with both monomethyl auristatin E and F and unambiguously define the trans-configuration of both ligands at the Val-Dil amide bond in their tubulin bound state. Moreover, we illustrate how peptidic vinca-site agents carrying terminal carboxylate residues may exploit an observed extended hydrogen bond network with the M-loop Arg278 to greatly improve the affinity of the corresponding analogs and to maintain the M-loop in an incompatible conformation for productive lateral tubulin-tubulin contacts in microtubules. Our results highlight a potential, previously undescribed molecular mechanism by which peptidic vinca-site agents maintain unparalleled potency as microtubule-destabilizing agents.},
doi = {10.1371/journal.pone.0160890},
journal = {PLoS ONE},
number = 8,
volume = 11,
place = {United States},
year = {2016},
month = {8}
}
https://doi.org/10.1371/journal.pone.0160890
Web of Science
Works referenced in this record:
Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications
journal, December 2014
- Maderna, Andreas; Doroski, Matthew; Subramanyam, Chakrapani
- Journal of Medicinal Chemistry, Vol. 57, Issue 24
Structural basis for the regulation of tubulin by vinblastine
journal, May 2005
- Gigant, Benoît; Wang, Chunguang; Ravelli, Raimond B. G.
- Nature, Vol. 435, Issue 7041
Molecular characterization of human stathmin expressed in Escherichia coli: site-directed mutagenesis of two phosphorylatable serines (Ser-25 and Ser-63)
journal, June 1994
- Curmi, P. A.; Maucuer, A.; Asselin, S.
- Biochemical Journal, Vol. 300, Issue 2
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
journal, August 2003
- Francisco, Joseph A.; Cerveny, Charles G.; Meyer, Damon L.
- Blood, Vol. 102, Issue 4
Dolastatin 10, a powerful cytostatic peptide derived from a marine animal
journal, June 1990
- Bai, Ruoli; Petit, George R.; Hamel, Ernest
- Biochemical Pharmacology, Vol. 39, Issue 12
Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules
journal, December 2015
- Wang, Yuxi; Benz, Frederick W.; Wu, Yangping
- Molecular Pharmacology, Vol. 89, Issue 2
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
journal, January 2013
- Prota, Andrea E.; Bargsten, Katja; Zurwerra, Didier
- Science, Vol. 339, Issue 6119
Microtubules as a target for anticancer drugs
journal, April 2004
- Jordan, Mary Ann; Wilson, Leslie
- Nature Reviews Cancer, Vol. 4, Issue 4
Variations in the colchicine-binding domain provide insight into the structural switch of tubulin
journal, August 2009
- Dorleans, A.; Gigant, B.; Ravelli, R. B. G.
- Proceedings of the National Academy of Sciences, Vol. 106, Issue 33
Dynamic instability of microtubule growth
journal, November 1984
- Mitchison, Tim; Kirschner, Marc
- Nature, Vol. 312, Issue 5991
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
journal, June 2003
- Doronina, Svetlana O.; Toki, Brian E.; Torgov, Michael Y.
- Nature Biotechnology, Vol. 21, Issue 7
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
journal, November 2008
- Lewis Phillips, G. D.; Li, G.; Dugger, D. L.
- Cancer Research, Vol. 68, Issue 22
A designed ankyrin repeat protein selected to bind to tubulin caps the microtubule plus end
journal, July 2012
- Pecqueur, Ludovic; Duellberg, Christian; Dreier, Birgit
- Proceedings of the National Academy of Sciences, Vol. 109, Issue 30
Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity
journal, January 2006
- Doronina, Svetlana O.; Mendelsohn, Brian A.; Bovee, Tim D.
- Bioconjugate Chemistry, Vol. 17, Issue 1
The binding conformation of Taxol in -tubulin: A model based on electron crystallographic density
journal, April 2001
- Snyder, J. P.; Nettles, J. H.; Cornett, B.
- Proceedings of the National Academy of Sciences, Vol. 98, Issue 9
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
journal, May 2014
- Alushin, Gregory M.; Lander, Gabriel C.; Kellogg, Elizabeth H.
- Cell, Vol. 157, Issue 5
Mechanistic Origin of Microtubule Dynamic Instability and Its Modulation by EB Proteins
journal, August 2015
- Zhang, Rui; Alushin, Gregory M.; Brown, Alan
- Cell, Vol. 162, Issue 4
The Determinants That Govern Microtubule Assembly from the Atomic Structure of GTP-Tubulin
journal, September 2011
- Nawrotek, Agata; Knossow, Marcel; Gigant, Benoît
- Journal of Molecular Biology, Vol. 412, Issue 1
Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
journal, January 2014
- Prota, Andrea E.; Bargsten, Katja; Northcote, Peter T.
- Angewandte Chemie International Edition, Vol. 53, Issue 6
Mitosis is not a key target of microtubule agents in patient tumors
journal, February 2011
- Komlodi-Pasztor, Edina; Sackett, Dan; Wilkerson, Julia
- Nature Reviews Clinical Oncology, Vol. 8, Issue 4
Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin a, dolastatins 10 and 15 and halichondrin B
journal, January 1992
- Hamel, Ernest
- Pharmacology & Therapeutics, Vol. 55, Issue 1
Structural insight into the inhibition of tubulin by vinca domain peptide ligands
journal, September 2008
- Cormier, Anthony; Marchand, Matthieu; Ravelli, Raimond B. G.
- EMBO reports, Vol. 9, Issue 11
Role of GTP hydrolysis in microtubule dynamics: information from a slowly hydrolyzable analogue, GMPCPP.
journal, October 1992
- Hyman, A. A.; Salser, S.; Drechsel, D. N.
- Molecular Biology of the Cell, Vol. 3, Issue 10
The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization
journal, April 2014
- Prota, Andrea E.; Danel, Franck; Bachmann, Felix
- Journal of Molecular Biology, Vol. 426, Issue 8
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
journal, August 2014
- Prota, A. E.; Bargsten, K.; Diaz, J. F.
- Proceedings of the National Academy of Sciences, Vol. 111, Issue 38
Structural basis of tubulin tyrosination by tubulin tyrosine ligase
journal, January 2013
- Prota, Andrea E.; Magiera, Maria M.; Kuijpers, Marijn
- The Journal of Cell Biology, Vol. 200, Issue 3
Microtubule Polymerization Dynamics
journal, November 1997
- Desai, Arshad; Mitchison, Timothy J.
- Annual Review of Cell and Developmental Biology, Vol. 13, Issue 1
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
journal, March 2004
- Ravelli, Raimond B. G.; Gigant, Benoît; Curmi, Patrick A.
- Nature, Vol. 428, Issue 6979